DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Adam Steensberg - 3 Jaap Arriens - 1 Eli Lilly - 1 Steensberg - 1
Top related locs:
U.S
Top related orgs:
Zealand Pharma - 3 Novo Nordisk - 1 CNBC - 1 pharma - 1 Nordisk - 1 Union - 1 Getty - 1

Search resuls for: "Steensberg"


3 mentions found


☆ Novo and Eli contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'
  + stars: | 2024-10-11 | by ( Karen Gilchrist | ) www.cnbc.com   time to read: +4 min
Jaap Arriens | NurPhotoDanish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly . Last month, Zealand Pharma announced positive top-line results from a phase 1b trial of its weight-loss drug, a GLP-1/GLP-2 receptor dual agonist called Dapiglutide. Stock Chart Icon Stock chart icon Zealand Pharma. Novo Nordisk is also experimenting with its own version of the treatment, combining the GLP-1 component Semaglutide with amylin analog Cagrilintide in a candidate called CagriSema. Syringes from weight loss drugs "Wegovy," "Ozempic" and "Mounjaro."
Persons: Jaap Arriens, Eli Lilly, Adam Steensberg, Steensberg Organizations: Zealand Pharma, Novo Nordisk, CNBC, pharma, Nordisk, Union, Getty Locations: U.S
☆ Zealand Pharma targeting 'next generation' of obesity drugs, CEO says
  + stars: | 2024-10-11 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZealand Pharma targeting 'next generation' of obesity drugs, CEO saysZealand Pharma's CEO Adam Steensberg weighs in on early-stage trials of its obesity drug contender and talks down takeover speculation.
Persons: Adam Steensberg Organizations: Zealand Pharma
☆ Zealand Pharma CEO: Magnitude of obesity pandemic requires many more solutions
  + stars: | 2024-03-01 | by ( ) www.cnbc.com   time to read: 1 min
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailZealand Pharma CEO: Magnitude of obesity pandemic requires many more solutionsAdam Steensberg, Zealand Pharma CEO, joins 'Money Movers' to discuss the goal for the company's weight loss drugs, the company's drug around liver disease, and more.
Persons: Adam Steensberg Organizations: Zealand Pharma
0 next >>
Total: 3